Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Todos Medical Ltd (OP: TOMDF ) 0.0001 UNCHANGED Last Price Updated: 11:20 AM EDT, Sep 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Todos Medical Ltd < Previous 1 2 3 4 5 6 7 Next > Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer's Paxlovid Approval, Tollovir(TM) Phase 2 & COVID Testing December 23, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 Todos Medical Announces New cPass Neutralizing Antibody Testing Reference Lab Agreement for CLIA/CAP Lab Provista with Physician Group in 40 States December 22, 2021 Provista completed validation for fingerprick At-Home sample collection of blood for the cPass neutralizing antibody test New York, NY, and Tel Aviv, ISRAEL... Via Benzinga Todos Medical Appoints Valentino Smith, MBA as Vice President of Marketing December 22, 2021 Company retains iiiNTENT SAAS artificial intelligence marketing service for Tollovid® and Tollovid Daily™ 3CL protease inhibitor dietary supplement products... Via Benzinga Todos Medical Announces New cPass Neutralizing Antibody Testing Reference Lab Agreement for CLIA/CAP Lab Provista with Physician Group in 40 States December 22, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Todos Medical Appoints Valentino Smith, MBA as Vice President of Marketing December 20, 2021 Company retains iiiNTENT SAAS artificial intelligence marketing service for Tollovid® and Tollovid Daily™ 3CL protease inhibitor dietary supplement products New York,... Via Benzinga Todos Medical Appoints Valentino Smith, MBA as Vice President of Marketing December 20, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Artificial Intelligence Exposures Artificial Intelligence Todos Medical Announces "Test & Tollovid®" Holiday Package for Atlanta Area at Provista Diagnostics December 17, 2021 New York, NY, and Tel Aviv, ISRAEL – December 17, 2021 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today... Via Benzinga Todos Medical to Host Key Opinion Leader Webinar Entitled Tollovir™: a Potential Treatment for Covid-19 December 16, 2021 Webinar to be held on December 22nd @ 12pm EST NLC Pharma and Todos agree to extend closing date for formation of 3CL Sciences to December 31, 2021 while the companies... Via Benzinga Todos Medical to Host Key Opinion Leader Webinar Entitled Tollovir(TM): a Potential Treatment for Covid-19 December 16, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Todos Medical Enters 90-Day Extension of Agreement with Convertible Note Holders on Moratorium on Conversions of Convertible Notes December 13, 2021 New York, NY, Alpharetta, GA and Tel Aviv, ISRAEL – December 13, 2021 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company... Via Benzinga Todos Medical Announces "Test & Tollovid(R)" Holiday Package for Atlanta Area at Provista Diagnostics December 17, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Todos Medical Enters 90-Day Extension of Agreement with Convertible Note Holders on Moratorium on Conversions of Convertible Notes December 13, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Todos Medical Interview and Presentation on Benzinga's All Access Conference Live December 14th at 10:20 AM EST December 10, 2021 New York, NY, and Tel Aviv, ISRAEL – December 10, 2021 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today... Via Benzinga Todos Medical Interview and Presentation on Benzinga's All Access Conference Live December 14th at 10:20 AM EST December 10, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Todos Medical Announces 2 New COVID-19 PCR Testing Reference Lab Agreements for CLIA/CAP Lab Provista Diagnostics December 07, 2021 Combined testing from two contracts averages 1000 PCR samples per day Testing potential for the two contracts could ramp up to 5000 PCR samples per day New York, NY, Alpharetta... Via Benzinga Exposures COVID-19 Todos Medical Announces 2 New COVID-19 PCR Testing Reference Lab Agreements for CLIA/CAP Lab Provista Diagnostics December 07, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Todos Medical to Present at Upcoming Emerging Growth Conference December 07, 2021 New York, NY, and Tel Aviv, ISRAEL – December 6, 2021 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today... Via Benzinga Todos Medical to Present at Upcoming Emerging Growth Conference December 06, 2021 New York, NY, and Tel Aviv, ISRAEL - (NewMediaWire) - December 6, 2021 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that... Via NewMediaWire Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir® Phase 2 Clinical Trial in Hospitalized COVID-19 Patients Have Completed Study Participation December 02, 2021 Dr. Jules Mitchel now leading preparation for data lock and statistical analysis Business update call Today at 4:30PM EST New York, NY, and Tel Aviv, ISRAEL – December 2,... Via Benzinga Exposures COVID-19 Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir Phase 2 Clinical Trial in Hospitalized COVID-19 Patients Have Completed Study Participation December 02, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Todos Medical to Host Business Update Conference Call on December 2nd at 4:30 PM EST December 01, 2021 New York, NY, and Tel Aviv, ISRAEL – December 1, 2021 - Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related... Via Benzinga Todos Medical to Host Business Update Conference Call on December 2nd at 4:30 PM EST December 01, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Todos Medical Confirms SARS-CoV-2 PCR Test Kits Used at CLIA/CAP Lab Provista Diagnostics Detect Omicron Variant November 30, 2021 Provista to also utilize e Osang’s High-Capacity Reflex Variant PCR Detection Kit that has been confirmed to identify the Omicron variant New York, NY, and Tel Aviv, ISRAEL... Via Benzinga Todos Medical Confirms SARS-CoV-2 PCR Test Kits Used at CLIA/CAP Lab Provista Diagnostics Detect Omicron Variant November 30, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma November 30, 2021 Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of variant-agnostic COVID-19 antivirals such as Tollovir that utilize the 3CL... Via Benzinga Topics Intellectual Property Exposures COVID-19 Intellectual Property Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma November 29, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Todos Medical Announces Exclusive License & Distribution Agreement with T-Cell Protect Hellas S.A. for Tollovid(R) Products Covering 30 Countries in Europe November 24, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Todos Medical Receives Purchase Order for 50,000 Bottles of Tollovid Daily from Its European Distribution Partner T-Cell Protect Hellas S.A for Initial Market Launch in Greece November 22, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Todos Medical Receives Purchase Order for 50,000 Bottles of Tollovid Daily™ from Its European Distribution Partner T-Cell Protect Hellas S.A for Initial Market Launch in Greece November 22, 2021 T-Cell Protect is also evaluating expected demand for maximum strength Tollovid® New York, NY, and Tel Aviv, ISRAEL – November 22, 2021 - Todos Medical, Ltd. (OTCQB:... Via Benzinga Todos Medical Announces Completion of Enrollment for COVID-19 Oral Antiviral 3CLPro (Mpro) Inhibitor Tollovir® Phase 2 Clinical Trial Interim Analysis in Severe and Critical Hospitalized Patients November 19, 2021 Enrollment now paused in the randomized, double blind, placebo controlled clinical trial in severe and critical hospitalized COVID-19 patients to complete interim analysis Data... Via Benzinga Exposures COVID-19 < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.